Status:
COMPLETED
Neutrophil-to Lymphocyte and Monocyte-to-Lymphocyte Ratios in Exudative Pleural Effusion
Lead Sponsor:
Alexandria University
Conditions:
Effusion
Eligibility:
All Genders
18+ years
Brief Summary
Exudative pleural effusion (EPE) presents a diagnostic challenge, requiring accurate biomarkers to predict outcomes and guide treatment. The neutrophil-to-lymphocyte ratio (NLR) and monocyte-to-lympho...
Detailed Description
Pleural fluid NLR and MLR are reliable biomarkers for diagnosing malignant pleural effusion and predicting poorer survival outcomes. These ratios may be useful in clinical practice, especially in reso...
Eligibility Criteria
Inclusion
- adult patients aged 18-80 years with an EPE diagnosis confirmed by thoracentesis.
Exclusion
- Exclusion criteria included patients with a history of recent surgery, corticosteroid use, or those with mixed effusion types.
Key Trial Info
Start Date :
May 11 2025
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 26 2025
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT07003204
Start Date
May 11 2025
End Date
May 26 2025
Last Update
June 4 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chest Department -Faculty of Medicine
Alexandria, Egypt, Egypt, 11511